Author

Navin Bhatt

Observed names: N BHATT, N Bhatt, N.Y. Bhatt

Institution: Icahn School of Medicine at Mount Sinai

Observed institutions: George Washington University, The Ohio State University, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5114213800

Promising pharmacologic innovations in treating pulmonary fibrosis

2006 · N BHATT, C BARAN, et al. · Current Opinion in Pharmacology · 28

Genetic control of susceptibility to UV-induced immunosuppression by interacting quantitative trait loci

2000 · KE Clemens, G Churchill, et al. · Genes and Immunity · 14

Expert Consensus on the Screening, Treatment, and Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), and the Potential Future Role of Anti-fibrotics[asterisk] in a Treatment Paradigm for SSc-ILD: A Delphi Consensus Study

2019 · F.F. Rahaghi, M.E. Strek, et al. · 7

AML-581 Convenient Acute Promyelocytic Leukemia Consolidation Arsenic Trioxide Dosing Schedule

2024 · Navin Bhatt, Jonathan Feld · Clinical Lymphoma Myeloma & Leukemia

Convenient Acute Promyelocytic Leukemia Consolidation Arsenic Trioxide Dosing Schedule

2024 · Navin Bhatt, Jonathan Feld · Clinical Lymphoma Myeloma & Leukemia

The Effects of Pulmonary Vasodilators on Concomitant Systemic Sclerosis Related Pulmonary Hypertension and Interstitial Lung Disease

2020 · A. Vijayaraman, E. Homsy, et al.

Works count: 6

Citation count: 49

H-index: 3

I10-index: 2